The rs7903146 Variant in the <i>TCF7L2</i> Gene Increases the Risk of Prediabetes/Type 2 Diabetes in Obese Adolescents by Impairing β-Cell Function and Hepatic Insulin Sensitivity.

Abstract

In this study, we aimed to explore the mechanism by which <i>TCF7L2</i> rs7903146 risk allele confers susceptibility to impaired glucose tolerance (IGT) or type 2 diabetes (T2D) in obese adolescents. The rs7903146 variant in the <i>TCF7L2</i> gene was genotyped in a multiethnic cohort of 955 youths. All subjects underwent an oral glucose tolerance test with the use of the Oral Minimal Model to assess insulin secretion, and 33 subjects underwent a hyperinsulinemic-euglycemic clamp. In 307 subjects, a follow-up oral glucose tolerance test was repeated after 3.11 ± 2.36 years. The <i>TCF7L2</i> rs7903146 risk allele was associated with higher 2-h glucose levels in Caucasians (<i>P</i> = 0.006) and African Americans (<i>P</i> = 0.009), and a trend was seen also in Hispanics (<i>P</i> = 0.072). Also, the T allele was associated with decreased β-cell responsivity and IGT (<i>P</i> < 0.05). Suppression of endogenous hepatic glucose production was lower in subjects with the risk variant (<i>P</i> = 0.006). Finally, the odds of showing IGT/T2D at follow-up were higher in subjects carrying the minor allele (odds ratio 2.224; 95% CI 1.370-3.612; <i>P</i> = 0.0012). The rs7903146 variant in the <i>TCF7L2</i> gene increases the risk of IGT/T2D in obese adolescents by impairing β-cell function, and hepatic insulin sensitivity predicts the development of IGT/T2D over time.